InspireMD (NSPR) Misses Q3 EPS by 1c

InspireMD (NASDAQ: NSPR) reported Q3 EPS of ($0.15), $0.01 worse than the analyst estimate of ($0.14). Revenue for the quarter came in at $1.6 million versus the consensus estimate of $1.5 million.

For earnings history and earnings-related data on InspireMD (NSPR) click here.

You May Also Be Interested In

• Citi cuts Micron stock target, sees memory chip prices peaking in 2Q27
• Kiora Pharmaceuticals (KPRX) Tops Q2 EPS by 17c
• Alta Mesa Resources (AMR) Misses Q2 EPS by 128c